Chile ISP Registered Devices Teardown & Channel Map
A registry analysis of the 619 devices registered under Chile's ISP decree-controlled families, covering condom and syringe category skews, manufacturer countries, and titular concentration.
Chile ISP Registered Medical Devices Teardown: 619 Devices, Condom-and-Consumable Category Mix, Southeast-Asia-and-China Manufacturing Origin, and Titular (Registry-Holder) Channel Concentration
Chile represents one of the most stable, sophisticated, and transparent healthcare markets in Latin America. With a strong public healthcare system (FONASA) and a robust private network (Isapres), the country invests heavily in advanced medical technology. According to regional benchmarks, Chile's medical device market is valued at approximately $1.2 billion and is highly dependent on imports to meet clinical demand.
Historically, Chile’s regulatory body for health products, the Instituto de Salud Pública de Chile (ISP or ISPCH) — operating through the National Agency of Medicines (ANAMED) — maintained a very narrow mandatory registration system. Unlike Brazil (ANVISA) or Colombia (INVIMA), where almost all medical devices require formal registration, Chile historically focused its mandatory controls on a few high-risk or public-health sensitive product categories. However, with the recent implementation of new regulatory decrees, the market is transitioning toward a broader registry.
To help regulatory affairs, market access, and commercial operations teams target Chile, this article provides a detailed data teardown of the official ISP medical device register. Our analysis is based on the ISP registered medical device lists (April 2026 snapshot), comprising 619 active registrations across the decree-controlled categories, and is cross-referenced with the official ISPCH registered empresa list.
Skip to Your Scenario
To help you quickly navigate this comprehensive guide, select the scenario that best matches your current strategic objective:
- How many medical devices hold an ISP registro sanitario and how do they split by category? — Market sizing and scope limitations.
- Which manufacturer countries dominate Chile's register (the Southeast-Asia and China origin)? — Supply chain analysis and import trends.
- Which manufacturers are most registered (the condom and AED leaders)? — Competitor profiling and market share.
- Which Chilean titulares (registry holders) hold the most registrations, and what does that mean for channel access? — Distributor selection and regulatory risk.
- What is the legal framework (Código Sanitario, DS 825/1998, category decrees) behind this register? — Understanding supreme decrees.
- The 2026 Expansion: Exempt Decree No. 25 and Phased Implementation — Understanding the transition.
- Side-by-Side Regulatory Comparison: Southern Cone & Andean Markets — Chile vs. Argentina, Colombia, and Ecuador.
- Technical Performance Standards Under Supreme Decrees — Specific testing and conformity requirements.
- Post-Market Technovigilance and Safety Reporting Requirements — Vigilance reporting timelines.
- Detailed Step-by-Step ISP Registration Workflow — Navigating service code 9100003.
- Strategic Titular and Local-Representative Selection for Chile Market Entry — Commercial execution guidelines.
How many medical devices hold an ISP registro sanitario and how do they split by category?
To analyze Chile’s medical device register, one must first understand the concept of "Control Obligatorio" (Mandatory Control). In Chile, a product requires a formal Registro Sanitario (Sanitary Registration) only if it is governed by a specific supreme decree. For all other devices, imports require only a voluntary background review certificate (Certificación de Antecedentes) or standard customs clearance.
Our analysis of the 619 registrations in the ISP dataset reveals the following category split:
| Product Family (Official Decree-Controlled Category) | Number of Registrations | Percentage of Register | Key Examples in Dataset |
|---|---|---|---|
| Preservativos (Male Condoms - DS 342 & DS 93) | 275 | 44.4% | Latex condoms, ribbed condoms, lubricated lines |
| Jeringas con aguja hipodérmica (Syringes with Needle - DS 1887) | 85 | 13.7% | Disposable clinical syringes with pre-attached needles |
| Desfibriladores Externos Automatizados Portátiles (AEDs - DS 42) | 64 | 10.3% | Public-access defibrillators, clinical AED lines |
| Guantes de Examinación (Examination Gloves - DS 342) | 58 | 9.4% | Nitrile and latex examination gloves |
| Jeringas Hipodérmicas de un sólo uso (Syringes without Needle - DS 1887) | 55 | 8.9% | Standard single-use hypodermic syringes |
| Guantes Quirúrgicos (Surgical Gloves - DS 342) | 47 | 7.6% | Sterile surgical gloves, powder-free lines |
| Agujas hipodérmicas (Hypodermic Needles - DS 1887) | 29 | 4.7% | Sterile clinical hypodermic needles |
| Preservativos Femeninos (Female Condoms - DS 93) | 6 | 1.0% | Polyurethane female condoms |
| Total | 619 | 100.0% | Comprehensive ISP Control Registry |
The Significance of the Category Distribution
Male and female condoms represent 45.4% of the entire register (281 registrations combined), followed by gloves (surgical and examination) at 17.0% (105 registrations), and syringes/needles at 27.3% (169 registrations).
Together, these standard medical consumables and protective products account for nearly 90% of all registered items in Chile.
The outlier is Portable Automated External Defibrillators (AEDs), representing 10.3% of the register (64 registrations). AEDs were brought under mandatory control via Supreme Decree No. 42/2021 (effective in 2021) to regulate the sudden influx of public-use defibrillators in malls, schools, and transport hubs. For active medical device manufacturers, this AED registry serves as a model for how the ISP handles high-tech hardware registrations.
Which manufacturer countries dominate Chile's register (the Southeast-Asia and China origin)?
Analyzing the pais_de_origen (country of origin) field in the ISP dataset reveals a high concentration of manufacturing in Southeast Asia and China, reflecting the global supply chain for rubber latex and low-cost consumables:
- China: 168 registrations (27.1%) — Dominates syringes, needles, basic gloves, and low-cost AEDs.
- Malaysia: 111 registrations (17.9%) — The global hub for rubber-latex harvesting, dominating surgical and examination gloves.
- Thailand: 71 registrations (11.5%) — Another major latex hub, focused heavily on male condoms.
- United States: 58 registrations (9.4%) — Combined "Estados Unidos" [46] and "EE.UU" [12]) — Dominates the high-tech AED segment.
- India: 39 registrations (6.3%) — Syringes, needles, and basic consumables.
- Germany: 37 registrations (6.0%) — Combined "Alemania" [25] and "República de Alemania" [12]) — Sterile surgical gloves and clinical syringes.
Manufacturer Country of Origin Share (619 Total):
China: ██████████████████████████ 168 (27.1%)
Malaysia: █████████████████ 111 (17.9%)
Thailand: ███████████ 71 (11.5%)
United States: █████████ 58 (9.4%)
India: ██████ 39 (6.3%)
Germany: ██████ 37 (6.0%)
Others: ████████████ 135 (21.8%)
This distribution highlights the geographical specialization of medtech manufacturing. Over 56% of Chile's registered devices are manufactured in China, Malaysia, or Thailand, representing the rubber-producing and low-cost syringe assembly lines of Asia.
On the other hand, the United States and Germany maintain their presence via high-value active devices (defibrillators by Zoll Medical or Physio-Control) and premium surgical consumables. For companies looking to manufacture locally in South America, this data confirms that Chile is almost entirely import-dependent for these controlled device classes.
Which manufacturers are most registered (the condom and AED leaders)?
Our analysis identifies approximately 277 distinct manufacturers holding approvals in Chile. The leading manufacturers by record count are:
- Suretex Limited (24 registrations): A global condom manufacturing giant, producing lines in Thailand and India for multiple international brands.
- Zoll Medical Corporation (19 registrations): The US leader in resuscitation technology, dominating the AED register.
- Reckitt Benckiser HealthCare (UK) Limited (17 registrations): The legal manufacturer of Durex condom lines.
- C.P.R. GmbH (12 registrations): A German manufacturer specializing in condoms and lubricants.
- Pleasure Latex Products Sdn. Bhd. (11 registrations): A Malaysian OEM condom manufacturer.
- Karex Industries Sdn. Bhd. (10 registrations): The world’s largest condom manufacturer, based in Malaysia, manufacturing for global private labels.
This manufacturer ranking highlights the dominance of OEM manufacturers in the register. Companies like Karex, Suretex, and Pleasure Latex manufacture products that are imported and commercialized under different brand names in Chile, demonstrating the high level of private-label outsourcing in the condom and glove sectors.
Which Chilean titulares (registry holders) hold the most registrations, and what does that mean for channel access?
In Chile, the Titular del Registro Sanitario (Sanitary Registration Holder) is the legal owner of the product approval. Under Chilean law, the titular must be a legal entity physically located and registered in Chile (such as a local subsidiary or an authorized representative/distributor).
Our data reveals an extreme concentration among the 183 distinct titulares in the register:
| Titular del Registro (Chilean Entity) | Registrations Held | Corporate Focus | Key Brands Represented |
|---|---|---|---|
| Laboratorios Prater S.A. | 35 | Local Pharma / MedTech | Lifestyle, condoms, local diagnostics |
| Farmaceutica Med - Cell S.A. | 31 | Local Representative | Imported syringes, needles, gloves |
| Reutter S.A. | 23 | Large Medical Distributor | Consumables, clinical gloves (Mölnlycke, etc.) |
| Becton Dickinson Chile Ltda. | 17 | Local Subsidiary | BD clinical syringes, needles, safety lines |
| Munnich Pharma Medical Ltda. | 17 | Local Representative | Medical gloves, syringes, local brands |
| Reckitt Benckiser Chile S.A. | 17 | Subsidiary | Durex condom portfolios |
| Nipro Medical Corporation Chile | 14 | Local Subsidiary | Nipro syringes, needles, dialysis lines |
Corroboration with the ISPCH Empresa List
This titular ranking is independently corroborated by the official ISPCH registered enterprise list (Lista de Empresas). The registry numbers assigned to these firms match their corporate authorizations:
- Laboratorios Prater S.A. operates under establishment code DM/005/05.
- Reutter S.A. operates under establishment code DM/002/05.
- Nipro Medical Corporation Chile operates under establishment code DM/006/05.
- Reckitt Benckiser Chile operates under establishment code EDM 108/11.
Strategic Implications for Market Entry
This data shows that the channel for controlled devices in Chile is divided between multinational subsidiaries (BD, Reckitt, Nipro) who hold their own registrations, and specialized representatives (Prater, Med-Cell, Reutter) who manage registrations for dozens of foreign manufacturers.
For a foreign manufacturer without a local Chilean office:
- Appointing a distributor like Reutter or Med-Cell as your titular means they legally own the registration.
- If you need to change distributors due to underperformance, the transfer process requires the current titular to sign a formal transfer deed. If the relationship has deteriorated, they can refuse or demand financial compensation, effectively blocking your products from the market during the transition.
- Recommendation: To avoid this channel lock-in, international manufacturers should structure contracts carefully, utilize neutral third-party registration holders, or establish a local subsidiary if the market volume justifies the cost.
What is the legal framework (Código Sanitario, DS 825/1998, category decrees) behind this register?
The regulatory framework governing medical devices in Chile is anchored in Article 111 of the Health Code (Código Sanitario), which gives the Ministry of Health (MINSAL) and the ISP the legal authority to control health products. The core administrative regulation is Supreme Decree No. 825/1998 ("Reglamento de control de productos y elementos de uso médico").
Under this framework, mandatory control is implemented through product-specific decrees:
- Supreme Decree No. 342/2004: Establishes mandatory sanitary control for male condoms and medical gloves (surgical and examination).
- Supreme Decree No. 93/2018: Incorporates female condoms into the mandatory control regime.
- Supreme Decree No. 1887/2007: Brings hypodermic needles and syringes under mandatory registry control.
- Supreme Decree No. 42/2021: Brings portable Automated External Defibrillators (AEDs) under mandatory control.
The 2026 Expansion: Exempt Decree No. 25 and Phased Implementation
While the historical register of 619 devices is narrow, the regulatory landscape in Chile changed dramatically with the publication of Exempt Decree No. 25 on March 19, 2026 (published in Chile's Diario Oficial). This decree represents the most significant regulatory expansion in Chile in three decades.
The Scope of the New Decree
Exempt Decree No. 25 incorporates 39 additional categories of medical devices and IVDs into the mandatory sanitary control regime. The newly regulated categories focus on critical clinic technologies, including:
- Diagnostic Imaging Equipment: X-ray systems, MRI scanners, ultrasound transducers, and CT scanners.
- Critical Care and Monitoring: Patient monitors, pulse oximeters, electrocardiographs (ECG), and fetal monitors.
- Therapeutic Equipment: Infusion pumps, electrosurgical units (ESU), and anesthesia workstations.
- Critical Hospital Systems: Steam and ethylene oxide (EtO) sterilizers, mechanical ventilators, and clinical defibrillators.
- Software as a Medical Device (SaMD): Clinical decision support systems and AI-based diagnostic software.
The Phased Implementation Timeline
To allow the industry and the ISP to adapt, the Ministry of Health established a phased implementation schedule:
+---------------------------------------------------------------------------------+
| Exempt Decree 25 Timeline |
+---------------------------------------------------------------------------------+
|
[March 19, 2026] -> Exempt Decree No. 25 published (Diario Oficial)
|
[Transition window] -> ISP issues the technical instructivo / product
nomenclature (UMDNS/GMDN); voluntary conformity
submissions accepted before mandatory deadlines
|
[≈ Month 24 (March 2028)] -> Mandatory conformity verification, Group 1 devices
|
[≈ Month 36 (March 2029)] -> Mandatory conformity verification, Group 2 devices
Foreign manufacturers of these newly regulated categories should not wait for the mandatory deadlines. Applying for the voluntary Certification of Background Review now provides a significant first-mover advantage, establishing your regulatory channel before the ISP's electronic portal (SAFIS) becomes backlogged with thousands of new filings in 2028.
Side-by-Side Regulatory Comparison: Southern Cone & Andean Markets
For regional managers, understanding how Chile compares with neighboring Latin American markets is essential for resource allocation:
| Regulatory Parameter | Chile (ISP) | Argentina (ANMAT) | Colombia (INVIMA) | Ecuador (ARCSA) |
|---|---|---|---|---|
| Mandatory Scope | Decree-Controlled Only | All Medical Devices | All Medical Devices | All Medical Devices |
| Local Holder | Titular (Chilean) | Importador Autorizado | Apoderado / Importador | Titular de Registro |
| Processing Code | Código 9100003 | Tramite online (HELENA) | Tramite Manual/Online | Sistema ARCSA |
| Official Timeline | 60 Working Days | 90 - 180 Days | 90 - 180 Days | 60 - 90 Days |
| Audit/GMP Audits | Factory certificate | Local / Reference Audit | Local / Reference Audit | Factory certificate |
| Validity Period | 3 Years (Auto-renew) | 5 Years | 10 Years | 5 Years |
| Reference Recognition | Low (Direct evaluation) | High (FDA, CE, etc.) | High (FDA, CE, etc.) | High (FDA, CE, etc.) |
Technical Performance Standards Under Supreme Decrees
To successfully pass the ISP technical evaluation in Chile, manufacturers must provide detailed test records demonstrating compliance with specific supreme decrees:
1. Medical Gloves (DS 342/2004)
The ISP enforces strict criteria for surgical and examination gloves:
- Standards: Must meet ISO 10282 (for surgical gloves) or ISO 11193 (for examination gloves).
- Requirements: Tests must prove dimensional tolerance, water-tightness (freedom from holes, AQL 1.5 or lower), force at break, and sterilization validation (for surgical lines).
2. Hypodermic Needles and Syringes (DS 1887/2007)
Consumables used for clinical injections must comply with the following standards:
- Needles: ISO 7864 (clinical hypodermic needles) and ISO 9626 (stainless steel needle tubing).
- Syringes: ISO 7886 (sterile single-use hypodermic syringes) and ISO 594 (Luer slip or Luer lock fittings).
- Technical Files: Biocompatibility testing under ISO 10993 (including cytotoxicity, sensitization, and intracutaneous reactivity) is mandatory.
3. Automated External Defibrillators (AEDs - DS 42/2021)
AEDs represent the most complex technology currently controlled:
- Standards: Must comply with IEC 60601-1 (general safety requirements for medical electrical equipment) and IEC 60601-2-4 (particular requirements for the safety of cardiac defibrillators).
- Clinical Data: Detailed reviews demonstrating clinical efficacy and safety of the specific shock waveform.
Post-Market Technovigilance and Safety Reporting Requirements
Once a medical device has successfully secured its registration certificate and cleared customs, it enters the post-market phase. Under Supreme Decree No. 825/1998, the ISP maintains a dedicated department for Technovigilance (Tecnovigilancia). The local titular and importers are bound by strict safety gates:
- Adverse Event Definition: Any malfunction, deterioration in the characteristics or performance of the medical device, or inadequacy in the labeling or the instructions for use that led to or could have led to the death of a patient or user, or a serious deterioration in their state of health.
- Reporting Timelines: The titular must report serious adverse events to the ISP within 5 working days of receiving notice. Non-serious events must be reported in consolidated quarterly safety reports.
- Sanctions for Non-Compliance: Failure to report adverse events or delays in executing field safety corrective actions (FSCAs) can result in administrative audits, suspension of the registration certificate, and monetary fines expressed in UTM (Unidad Tributaria Mensual).
Detailed Step-by-Step ISP Registration Workflow
To secure an ISP Registro Sanitario in Chile under the standard service code 9100003, the local titular must execute the following workflow:
+---------------------------------------------------------------------------------+
| Chile ISP Workflow |
+---------------------------------------------------------------------------------+
|
[Step 1: Empresa Registration] -> Titular registers company with ISPCH
|
[Step 2: Warehouse Inspection] -> Secures sanitary storage permit (CDA)
|
[Step 3: Dossier Assembly] -> Technical file + Legalized FSC + ISO 13485
|
[Step 4: SAFIS Portal Upload] -> Submit via online portal & pay fee
|
[Step 5: Quality Audit & Review] -> ISP technical and packaging evaluation
|
[Step 6: Registro Issued] -> Secure 3-year certificate (auto-renew)
Step 1: Registration of the Local Empresa
The local entity (titular) must register with the ISPCH database to secure their company code (e.g., DM/005/05). This requires submitting the company's legal constitution, representative authorizations, and commercial address.
Step 2: Warehouse Authorization (Certificado de Destinación Aduanera - CDA)
The titular must hold a valid sanitary warehouse authorization issued by the SEREMI de Salud (regional health authority). The storage site must pass physical inspections verifying temperature controls, separation of quarantined items, and inventory tracking.
Step 3: Technical Dossier Compilation
Compile the technical dossier. For decree-controlled devices, the ISP requires:
- Legalized Free Sale Certificate (FSC): Proof of approval in the country of origin, legalized by the Chilean consulate or apostilled.
- ISO 13485:2016 Certificate: Quality management certification of the manufacturing facility.
- Conformity Certificates: Specific test reports demonstrating compliance with local Chilean standards (e.g., specific latex strength tests for condoms, electrical safety tests for AEDs).
- Spanish Labeling: High-resolution artwork of the packaging. Labels and instructions must be entirely in Spanish, detailing the titular's name, RUT (tax ID), and the ISP registry number.
Step 4: Submission via SAFIS Portal
The titular uploads the compiled dossier to the ISPCH’s SAFIS electronic platform and pays the government fee. The fee depends on the specific device category and is updated annually in UTM (unidad tributaria mensual, a Chilean inflation-indexed unit).
Step 5: Technical and Quality Review
ISP reviewers evaluate the dossier.
- Deficiency Resolution: If technical gaps are identified, the ISP issues a deficiency notification. The titular must respond within 30 working days. Failure to respond results in dossier cancellation.
- For condoms and gloves, the ISP may require physical sample testing at approved Chilean laboratories (e.g., IDIEM or CEPRI) before final clearance is granted.
Step 6: Issuance of the Registro Sanitario
Upon successful review, the ISP issues the Sanitary Registration Certificate. The product is added to the public database of "Dispositivos Médicos con Registro Sanitario," allowing the titular to secure import permits. The registration is valid for 3 years and features automatic renewal if no safety issues are reported.
Strategic Titular and Local-Representative Selection for Chile Market Entry
The quantitative realities of the ISP register (with firms like Laboratorios Prater holding 35 registrations and Reutter holding 23) suggest the following commercial strategies:
- Separate Regulatory Ownership from Commercial Sales: To avoid channel lock-in, international firms should work with a specialized local regulatory consultancy in Santiago to act as the legal titular. The consultant holds the ISP registration, while you contract multiple commercial distributors (like Reutter) to handle sales.
- Monitor the Expansion of Mandatory Control (Exempt Decree No. 25): While the historical register contains only 619 devices, the Chilean Ministry of Health is actively expanding the list of controlled products. Manufacturers of diagnostic imaging equipment, infusion pumps, and clinical monitors must prepare for the new mandatory registration rules.
- Ensure Compliance with Local Testing Standards: For consumable and rubber products, do not assume that a CE Mark is sufficient. The ISP requires specific test protocols (e.g., local batch testing for condoms). Ensure your manufacturing partner can provide raw data files to meet these Chilean-specific requirements.
Related Articles
To complete your Latin American medtech market strategy, explore our companion guides:
- Chile ISP Medical Device Registration Guide — Our detailed process guide covering how to compile a dossier, fee schedules, and importer licensing steps.
- Argentina ANMAT Medical Device Register Market Analysis — Analyzing regulatory pathways and southern-cone market entry.
- Colombia INVIMA Importer and Apoderado Concentration and Channel Lock-in Analysis — Deep dive into Colombian channel structure and regulatory hold models.
- Ecuador ARCSA Medical Device Register Analysis — Navigating the Andean market registry and representative requirements.
Disclaimer: The data presented in this article is based on the official Instituto de Salud Pública de Chile (ISPCH) registered medical device category lists snapshot as of April 2026. Company and titular record counts are approximate due to spelling and name-case variations in the public records. This analysis is for educational and commercial planning purposes and does not constitute formal legal or regulatory advice for specific products.